Indications and uses
helps prevent sunburn
BANANA BOAT
- Manufacturer
- Edgewell Personal Care Brands LLC
- Effective date
- 2020-12-11
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 10
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 23:02:21
Label at a glance#
ProductBANANA BOAT
Active ingredientAVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE
Label structure9 sections
Dosage and administration
hold container 4 to 6 inches from the skin to apply spray liberally and spread evenly by hand 15 minutes before sun exposure do not spray directly into face . Spray on hands then apply to face. do not apply in windy conditions use in well ventilated are reapply: after 80 minutes of swimming or sweating • immediately after towel drying • at least every 2 hours
Label contents#
Full prescribing information#
Active Ingredients
Avobenzone 3%
Homosalate 10%
Octisalate 5%
Octocrylene 6%
Purpose
Sunscreen
Uses
helps prevent sunburn
Warnings
- For external use only
- Flammable: Do not puncture or incinerate. Contents under pressure. Do not store at temperatures above 120°F. Do not use in presence of a flame or spark. Keep away from sources of ignition - No smoking.
- Intentional misuse by deliberately concentrating and inhaling the contents can be harmful or fatal.
- Do not use on damaged or broken skin
When using this product
- keep away from face to avoid breathing it
- keep out of eyes. Rinse with water to remove.
stop use and ask a doctor if
rash occurs
Keep out of reach of children
If product is swallowed, get medical help or contact a Poison Control Center right away.
Directions
- hold container 4 to 6 inches from the skin to apply
- spray liberally and spread evenly by hand 15 minutes before sun exposure
- do not spray directly into face. Spray on hands then apply to face.
- do not apply in windy conditions
- use in well ventilated are
- reapply: after 80 minutes of swimming or sweating • immediately after towel drying • at least every 2 hours
Other Information
Sun protection measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including:
- limit time in the sun, especially from 10 am - 2 pm
- wear long-sleeve shirts, pants, hats and sunglasses
- May stain some fabrics.
Inactive Ingredients
Isobutane, Water, Isohexadecane, Ethylhexyl Benzoate, Cetyl PEG/PPG-10/1 Dimethicone, Dibutyl Adipate, Lauryl PEG-8 Dimethicone, Ethylhexyl Methoxycrylene, Sodium Chloride, PEG-8, Caprylyl Glycol, Glycerin, Sodium Citrate, PEG-8 Dimethicone, Aloe Barbadensis Leaf Juice, Octyldodecanol, Retinyl Palmitate, Silica, Tocopheryl Acetate, Ascorbic Acid, Sodium Propoxyhydroxypropyl Thiosulfate Silica, Phenoxyethanol, Methylparaben, Butylparaben, Ethylparaben, Isobutylparaben, Propylparaben.
Questions or Comments?
Call 1-800 SafeSun, Mon-Fri
Principal Display Panel
LOTION
UltraMist®
Tear-Free
Sting-Free
BANANA
BOAT®
KIDS
UVA/UVB PROTECTION
CONTINUOUS SPRAY SUNSCREEN
50+
BROAD SPECTRUM
SPF 50+
WATER RESISTANT
(80 MINUTES)
NO ADDED FRAGRANCE
SWIM•SPLASH•SPORT
NET WT.
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63354-010-34 | 2023-11-16 | C162847 | 48780-1 | f386c649-9964-0266-e053-dadaa90a7c1a | 947e29fe-fc31-4858-82a3-1f65ce165f0b |
| 63354-010-36 | 2023-11-16 | C162847 | 48780-1 | f386c649-9964-0266-e053-dadaa90a7c1a | 947e29fe-fc31-4858-82a3-1f65ce165f0b |
| 63354-010-37 | 2023-11-16 | C162847 | 48780-1 | f386c649-9964-0266-e053-dadaa90a7c1a | 947e29fe-fc31-4858-82a3-1f65ce165f0b |
| 63354-010-34 | 2023-01-30 | C162847 | 48780-1 | f386c649-9964-0266-e053-dadaa90a7c1a | 947e29fe-fc31-4858-82a3-1f65ce165f0b |
| 63354-010-36 | 2023-01-30 | C162847 | 48780-1 | f386c649-9964-0266-e053-dadaa90a7c1a | 947e29fe-fc31-4858-82a3-1f65ce165f0b |
| 63354-010-37 | 2023-01-30 | C162847 | 48780-1 | f386c649-9964-0266-e053-dadaa90a7c1a | 947e29fe-fc31-4858-82a3-1f65ce165f0b |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| AVOBENZONE | ACTIVE INGREDIENT | G63QQF2NOX | 7 | |
| HOMOSALATE | ACTIVE INGREDIENT | V06SV4M95S | 7 | |
| OCTISALATE | ACTIVE INGREDIENT | 4X49Y0596W | 7 | |
| OCTOCRYLENE | ACTIVE INGREDIENT | 5A68WGF6WM | 7 | |
| AVOBENZONE | ACTIVE MOIETY | G63QQF2NOX | 7 | |
| HOMOSALATE | ACTIVE MOIETY | V06SV4M95S | 7 | |
| OCTISALATE | ACTIVE MOIETY | 4X49Y0596W | 7 | |
| OCTOCRYLENE | ACTIVE MOIETY | 5A68WGF6WM | 7 | |
| ALOE VERA LEAF | INACTIVE INGREDIENT | ZY81Z83H0X | 7 | |
| ASCORBIC ACID | INACTIVE INGREDIENT | PQ6CK8PD0R | 7 | |
| BUTYLPARABEN | INACTIVE INGREDIENT | 3QPI1U3FV8 | 7 | |
| CAPRYLYL GLYCOL | INACTIVE INGREDIENT | 00YIU5438U | 7 | |
| DIBUTYL ADIPATE | INACTIVE INGREDIENT | F4K100DXP3 | 7 | |
| ETHYLPARABEN | INACTIVE INGREDIENT | 14255EXE39 | 7 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 7 | |
| ISOBUTANE | INACTIVE INGREDIENT | BXR49TP611 | 7 | |
| ISOBUTYLPARABEN | INACTIVE INGREDIENT | 0QQJ25X58G | 7 | |
| ISOHEXADECANE | INACTIVE INGREDIENT | 918X1OUF1E | 7 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | 7 | |
| OCTYLDODECANOL | INACTIVE INGREDIENT | 461N1O614Y | 7 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 7 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | 7 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | 7 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 7 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | 7 | |
| SODIUM CITRATE | INACTIVE INGREDIENT | 1Q73Q2JULR | 7 | |
| VITAMIN A PALMITATE | INACTIVE INGREDIENT | 1D1K0N0VVC | 7 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 7 |
Products#
Every source-derived product name is available through these pages.
- BANANA BOAT
- AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE
- ISOBUTANE
- WATER
- ISOHEXADECANE
- DIBUTYL ADIPATE
- SODIUM CHLORIDE
- POLYETHYLENE GLYCOL 400
- CAPRYLYL GLYCOL
- GLYCERIN
- SODIUM CITRATE
- ALOE VERA LEAF
- OCTYLDODECANOL
- VITAMIN A PALMITATE
- SILICON DIOXIDE
- ASCORBIC ACID
- PHENOXYETHANOL
- METHYLPARABEN
- ETHYLPARABEN
- PROPYLPARABEN
- BUTYLPARABEN
- AVOBENZONE
- HOMOSALATE
- OCTISALATE
- OCTOCRYLENE
- ISOBUTYLPARABEN
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 63354-010 | 63354-010-34, 63354-010-36, 63354-010-37 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / AURICULAR (OTIC) | 18 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / PARENTERAL | 18 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / ORAL | 346 mg | ||
| OCTYLDODECANOL | OCTYLDODECANOL | 461N1O614Y | CREAM / VAGINAL | 13.5 %w/w | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | GEL / TOPICAL | 4 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION / SUBCUTANEOUS | 0.16 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / ORAL | 1126 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 226 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / SOFT TISSUE | 0.15 %w/v | ||
| ASCORBIC ACID | ASCORBIC ACID | PQ6CK8PD0R | SYRUP / ORAL | 200 mg | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | TABLET / ORAL | 193 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SPRAY / NASAL | 30 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | POWDER / ORAL | NA | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | SPRAY, METERED / NASAL | 320 mg | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | SYRUP / ORAL | 740 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CONCENTRATE / ORAL | 1800 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER / ORAL | 602 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | TABLET / ORAL | 231 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| ISOBUTANE | ISOBUTANE | BXR49TP611 | AEROSOL, SPRAY / TOPICAL | 4484 mg | ||
| OCTYLDODECANOL | OCTYLDODECANOL | 461N1O614Y | FILM / TRANSDERMAL | 32.44 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | CONCENTRATE / ORAL | 12 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION, CONCENTRATE / ORAL | 1 mg/1ml | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / NASAL | 140 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | POWDER / RESPIRATORY (INHALATION) | NA | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | LOTION / TOPICAL | 1 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / ORAL | 26208 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | DROPS / ORAL | 1 mg/1ml | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 0.8 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | CREAM / TOPICAL | 3000 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | DROPS / ORAL | NA | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | TABLET / ORAL | 0.2 mg | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | SUPPOSITORY / RECTAL | 0.25 mg/mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SUSPENSION, EXTENDED RELEASE / ORAL | 4 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION/ DROPS / TOPICAL | 0.23 %w/v | ||
| ASCORBIC ACID | ASCORBIC ACID | PQ6CK8PD0R | INJECTION, SOLUTION / INFILTRATION | 0.2 %w/v | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / TOPICAL | 6 mg | ||
| BUTYLPARABEN | BUTYLPARABEN | 3QPI1U3FV8 | TABLET, COATED / ORAL | 0.08 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / INTRAVENOUS | 90 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRAVENOUS | 95 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | SPONGE / TOPICAL | NA | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / RETROBULBAR | 648 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SPRAY / TOPICAL | 0.8 %w/w | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | SOLUTION, CONCENTRATE / ORAL | 2813 mg | ||
| ASCORBIC ACID | ASCORBIC ACID | PQ6CK8PD0R | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 1440 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1720 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FOR SUSPENSION / ORAL | 220 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SYRUP / ORAL | 40 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / INTRATYMPANIC | 2 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INFILTRATION | 3535 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRADERMAL | 1 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | GEL / VAGINAL | 10 %w/w | ||
| BUTYLPARABEN | BUTYLPARABEN | 3QPI1U3FV8 | TABLET / ORAL | NA | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | TABLET, COATED / ORAL | 0.8 mg | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | INJECTION, SOLUTION / INTRAVENOUS | 24186 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 0a4bad73-8740-1698-e063-6294a90a8f49 | 947e29fe-fc31-4858-82a3-1f65ce165f0b | 2023-11-16 | Warnings | 947e29fe-fc31-4858-82a3-1f65ce165f0b |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.